Lu Qiang, Xie Yuhong, Luo Jingbin, Gong Qihai, Li Cailan
Department of Pharmaceutical Sciences, Zhuhai Campus, Zunyi Medical University, Zhuhai, China.
Department of Pharmacology, Zhuhai Campus, Zunyi Medical University, Zhuhai, China.
Front Pharmacol. 2023 Jun 1;14:1168990. doi: 10.3389/fphar.2023.1168990. eCollection 2023.
Ulcerative colitis (UC) is a chronic aspecific gut inflammatory disorder that primarily involves the recta and colons. It mostly presents as a long course of repeated attacks. This disease, characterized by intermittent diarrhoea, fecal blood, stomachache, and tenesmus, severely decreases the living quality of sick persons. UC is difficult to heal, has a high recurrence rate, and is tightly related to the incidence of colon cancer. Although there are a number of drugs available for the suppression of colitis, the conventional therapy possesses certain limitations and severe adverse reactions. Thus, it is extremely required for safe and effective medicines for colitis, and naturally derived flavones exhibited huge prospects. This study focused on the advancement of naturally derived flavones from edible and pharmaceutical plants for treating colitis. The underlying mechanisms of natural-derived flavones in treating UC were closely linked to the regulation of enteric barrier function, immune-inflammatory responses, oxidative stress, gut microflora, and SCFAs production. The prominent effects and safety of natural-derived flavones make them promising candidate drugs for colitis treatment.
溃疡性结肠炎(UC)是一种慢性非特异性肠道炎症性疾病,主要累及直肠和结肠。它大多表现为病程漫长且反复发作。这种疾病以间歇性腹泻、便血、腹痛和里急后重为特征,严重降低了患者的生活质量。UC难以治愈,复发率高,且与结肠癌的发病率密切相关。尽管有多种药物可用于抑制结肠炎,但传统疗法存在一定局限性和严重不良反应。因此,极其需要治疗结肠炎的安全有效药物,而天然来源的黄酮类化合物展现出巨大前景。本研究聚焦于从食用和药用植物中提取的天然来源黄酮类化合物在治疗结肠炎方面的进展。天然来源黄酮类化合物治疗UC的潜在机制与肠道屏障功能、免疫炎症反应、氧化应激、肠道微生物群和短链脂肪酸产生的调节密切相关。天然来源黄酮类化合物的显著疗效和安全性使其成为治疗结肠炎的有前景的候选药物。